244 related articles for article (PubMed ID: 21970857)
1. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Wang J; Zhang K; Grabowska D; Li A; Dong Y; Day R; Humphrey P; Lewis J; Kladney RD; Arbeit JM; Weber JD; Chung CH; Michel LS
Mol Cancer Res; 2011 Dec; 9(12):1686-95. PubMed ID: 21970857
[TBL] [Abstract][Full Text] [Related]
2. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
[TBL] [Abstract][Full Text] [Related]
3. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
4. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
5. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
[TBL] [Abstract][Full Text] [Related]
6. Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
Zhang K; Jones L; Lim S; Maher CA; Adkins D; Lewis J; Kimple RJ; Fertig EJ; Chung CH; Van Tine BA; Ellis MJ; Herrlich A; Michel LS
Oncotarget; 2014 Oct; 5(19):9281-94. PubMed ID: 25238142
[TBL] [Abstract][Full Text] [Related]
7. Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.
Wang XD; Wang Q; Chen XL; Huang JF; Yin Y; Da P; Wu H
Mol Med Rep; 2015 Jul; 12(1):865-70. PubMed ID: 25779928
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis.
Li J; Zheng H; Yu F; Yu T; Liu C; Huang S; Wang TC; Ai W
Carcinogenesis; 2012 Jun; 33(6):1239-46. PubMed ID: 22491752
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte p38δ loss inhibits Ras-induced tumor formation, while systemic p38δ loss enhances skin inflammation in the early phase of chemical carcinogenesis in mouse skin.
Kiss A; Koppel AC; Anders J; Cataisson C; Yuspa SH; Blumenberg M; Efimova T
Mol Carcinog; 2016 May; 55(5):563-74. PubMed ID: 25753147
[TBL] [Abstract][Full Text] [Related]
11. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.
Palla AR; Piazzolla D; Alcazar N; Cañamero M; Graña O; Gómez-López G; Dominguez O; Dueñas M; Paramio JM; Serrano M
Sci Rep; 2015 May; 5():10205. PubMed ID: 25988972
[TBL] [Abstract][Full Text] [Related]
12. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.
Zhao W; Kuai X; Zhou X; Jia L; Wang J; Yang X; Tian Z; Wang X; Lv Q; Wang B; Zhao Y; Huang W
Oncol Rep; 2018 Aug; 40(2):759-766. PubMed ID: 29901160
[TBL] [Abstract][Full Text] [Related]
13. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
Cataisson C; Michalowski AM; Shibuya K; Ryscavage A; Klosterman M; Wright L; Dubois W; Liu F; Zhuang A; Rodrigues KB; Hoover S; Dwyer J; Simpson MR; Merlino G; Yuspa SH
Sci Signal; 2016 Jun; 9(433):ra62. PubMed ID: 27330189
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
15. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
16. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
18. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
19. Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling.
Stoyanova T; Goldstein AS; Cai H; Drake JM; Huang J; Witte ON
Genes Dev; 2012 Oct; 26(20):2271-85. PubMed ID: 23070813
[TBL] [Abstract][Full Text] [Related]
20. Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis.
Rachow S; Zorn-Kruppa M; Ohnemus U; Kirschner N; Vidal-y-Sy S; von den Driesch P; Börnchen C; Eberle J; Mildner M; Vettorazzi E; Rosenthal R; Moll I; Brandner JM
PLoS One; 2013; 8(2):e55116. PubMed ID: 23390516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
